Motor deficits and brain pathology in the Parkinson's disease mouse model hA53Ttg
- PMID: 39371610
- PMCID: PMC11450652
- DOI: 10.3389/fnins.2024.1462041
Motor deficits and brain pathology in the Parkinson's disease mouse model hA53Ttg
Abstract
Background: Parkinson's disease (PD) is a debilitating neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons and the accumulation of α-synuclein (α-syn) aggregates. The A53T missense point mutation occurs in autosomal dominant familial PD and has been found to promote the aggregation of α-syn. To investigate the role of the A53T mutation in PD, researchers have developed various mouse models with this mutation.
Objective: We therefore conducted a comprehensive characterization of the tg(THY1-SNCA*A53T)M53Sud mouse model (hA53Ttg mice) for its motor and pathological features.
Methods: hA53Ttg mice were tested for motor impairments in a series of motor tests at 2, 4 or 6 months of age. Human α-syn and α-syn pSer129, as well as GFAP and Iba1 signal were labeled and quantified in the cortex, hippocampus, and brainstem. Neurofilament light chain (NF-L) levels were measured in the cerebrospinal fluid (CSF) and plasma. Ex vivo analyses were performed at the age of 2, 4, 6, and 10 months.
Results: Behavioral tests revealed early muscle weakness and motor impairments that progressed with age. Immunohistochemical analyses demonstrated elevated levels of human α-syn and α-syn pSer129 in all evaluated brain regions. α-syn pSer129 labeling further revealed fiber-like structures in the cortex of older animals. Neuroinflammation was observed in an age-dependent manner. Biochemical evaluation revealed elevated NF-L levels in the plasma and CSF. Overall, our findings highlight the value of hA53Ttg mice in modeling PD-associated pathologies that closely resemble those observed in PD patients.
Conclusion: Our results thus suggest that hA53Ttg mice are a useful tool for studying the underlying mechanisms of PD.
Keywords: Parkinson’s disease; motor skills; neurodegeneration; neuroinflammation; transgenic mouse; α-synuclein.
Copyright © 2024 Breznik, Daurer, Rabl, Loeffler, Etxeberria-Rekalde, Neddens, Flunkert and Prokesch.
Conflict of interest statement
LB, MD, RR, TL, EE-R, JN, SF, and MP are employed by Scantox Neuro GmbH.
Figures
References
LinkOut - more resources
Full Text Sources
Miscellaneous
